ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

Rosen Law Firm announced a securities class action lawsuit against Beta Bionics (NASDAQ: BBNX) on behalf of investors who purchased shares between July 30, 2025 and February 24, 2026. The announcement introduces litigation risk for the medical-device company, though the release provides no allegations, claimed damages, or financial impact details.